Strilciuc, S.; Vécsei, L.; Boering, D.; Pražnikar, A.; Kaut, O.; Riederer, P.; Battistin, L.
Safety of Cerebrolysin for Neurorecovery after Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Twelve Randomized-Controlled Trials. Pharmaceuticals 2021, 14, 1297.
https://doi.org/10.3390/ph14121297
AMA Style
Strilciuc S, Vécsei L, Boering D, Pražnikar A, Kaut O, Riederer P, Battistin L.
Safety of Cerebrolysin for Neurorecovery after Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Twelve Randomized-Controlled Trials. Pharmaceuticals. 2021; 14(12):1297.
https://doi.org/10.3390/ph14121297
Chicago/Turabian Style
Strilciuc, Stefan, László Vécsei, Dana Boering, Aleš Pražnikar, Oliver Kaut, Peter Riederer, and Leontino Battistin.
2021. "Safety of Cerebrolysin for Neurorecovery after Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Twelve Randomized-Controlled Trials" Pharmaceuticals 14, no. 12: 1297.
https://doi.org/10.3390/ph14121297
APA Style
Strilciuc, S., Vécsei, L., Boering, D., Pražnikar, A., Kaut, O., Riederer, P., & Battistin, L.
(2021). Safety of Cerebrolysin for Neurorecovery after Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Twelve Randomized-Controlled Trials. Pharmaceuticals, 14(12), 1297.
https://doi.org/10.3390/ph14121297